Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015
-
Upload
nicholas-tatonetti -
Category
Science
-
view
442 -
download
0
Transcript of Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015
![Page 1: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/1.jpg)
Systems pharmacology for drug safety
November 15th, 2015
Nicholas P. Tatonetti, PhD Herbert Irving Assistant Professor of Biomedical Informatics
Columbia University
![Page 2: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/2.jpg)
Observation is the starting point of biological discovery
• Charles Darwin observed relationship between geography and phenotype
• William McBride & Widukind Lenz observed association between thalidamide use and birth defects
![Page 3: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/3.jpg)
The tools of observation are advancing
• Human senses
• sight, touch, hearing, smell, taste
• Mechanical augmentation
• binoculars, telescopes, microscopes, microphones
• Chemical and Biological augmentations
• chemical screening, microarrays, high throughput sequencing technology
• What’s next?
Bytes to KB
Megabytes to Terabytes
![Page 4: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/4.jpg)
The tools of observation are advancing
• Human senses
• sight, touch, hearing, smell, taste
• Mechanical augmentation
• binoculars, telescopes, microscopes, microphones
• Chemical and Biological augmentations
• chemical screening, microarrays, high throughput sequencing technology
• What’s next?
Bytes to KB
Megabytes to Terabytes
![Page 5: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/5.jpg)
Technological Augmentation
• Tech companies are becoming really good at observing (and recording) the moments of life
• Apple (iCloud)
• 2015, the year of the zetabyte
• 1 zetabyte = 1,000 exabytes = 1 billion terabytes
![Page 6: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/6.jpg)
Your doctor is observing you like never before
>99% of Hospitals have Electronic Health Records
![Page 7: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/7.jpg)
Your doctor is observing you like never before
>60% of ALL Physicians
![Page 8: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/8.jpg)
Every drug order is an experiment.
![Page 9: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/9.jpg)
Observation analysis in a petabyte world
• Darwin, McBride, and Lenz were working with kilobytes of data
• Today’s scientists are observing terabytes and petabytes of data
• The human mind simply cannot make sense of that much information
• Data mining is about making the tools of data analysis (“hypothesis generation”) catch up to the tools of observation
![Page 10: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/10.jpg)
But, there’s a problem…
![Page 11: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/11.jpg)
Bias confounds observations
![Page 12: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/12.jpg)
Databases of drug effects are confounded
• Most drug side effects are only discovered after drugs hit the market using observational data
• This leads to high false positive and false negative rates when using EHR and adverse event data to find side effects
A
B
A
![Page 13: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/13.jpg)
MWAS
Ryan et al. CPT: Pharmacometrics & Systems Pharmacology (2013)
False positivesFalse negatives
FN: Estradiol, DesipramineSensitivity: 67% 70%Specificity: 60% 60%
Myocardial InfarctionMedication-wide association study
![Page 14: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/14.jpg)
AE Protein
Protein
Protein
AETarget
Drug
We can use prior biological knowledge to improve pharmacovigilance programs.
![Page 15: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/15.jpg)
Systems pharmacology
• Integration of physiological, biochemical, genomic data to analyze drug actions and side effects in the context of the interactome
• Key method: network analysis
• Nodes = proteins and small molecules
• Edges = interactions
(aka systems pharmacology)
![Page 16: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/16.jpg)
MADSS
• Use network analysis to build AE neighborhoods: a subset of the interactome surrounding AE “seed” proteins
• Score each protein on connectivity to seeds
• Overarching hypothesis: drugs targeting proteins within an AE neighborhood more likely to be involved in mediating that AE
Modular Assembly of Drug Safety Subnetworks
Lorberbaum, et al. Clin. Pharmacol. Ther. (2015)
Protein
InteractionSeed protein
Adverse eventDrug known to cause AEDrug predicted to cause AE
![Page 17: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/17.jpg)
• For each AE, use four adapted pairwise connectivity metrics to score every protein in interactome on its connectivity to the seed set
• Mean first passage time (MFPT)
• Betweenness centrality (BC)
• Shared neighbors (SN)
• Inverse shortest path (ISP)
Building AE neighborhoods
Lorberbaum, et al. Clin. Pharmacol. Ther. (2015)
![Page 18: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/18.jpg)
Myocardial infarction
Lorberbaum, et al. Clin. Pharmacol. Ther. (2015)
![Page 19: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/19.jpg)
![Page 20: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/20.jpg)
Serotonin agonists (triptans): serotonin receptor activation can lead to vaso-constriction and increased synthesis of IL-6 (MI seed) in vascular smooth muscle
![Page 21: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/21.jpg)
Can we use these molecular data to
predict results of clinical trials or
post-market surveillance?
![Page 22: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/22.jpg)
Evaluating MADSS: Drug safety gold standard
• Gold standard for 4 AEs created using systematic literature review and natural language processing of structured product labeling
GI Bleeding (73) 24 positives49 negatives
Myocardial Infarct (73) 33 positives40 negatives
Liver Failure (89) 63 positives26 negatives
Kidney Failure (49) 19 positives30 negatives
![Page 23: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/23.jpg)
MWAS
Ryan et al. CPT: Pharmacometrics & Systems Pharmacology (2013)
False positivesFalse negatives
FN: Estradiol, DesipramineSensitivity: 67% 70%Specificity: 60% 60%
Myocardial InfarctionMedication-wide association study
![Page 24: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/24.jpg)
Evaluating MADSS: Subnetwork (SubNet) models
• Trained SubNet model for each AE individually using connectivity scores as features
• Evaluated MWAS alone, SubNet alone, MWAS+SubNet
![Page 25: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/25.jpg)
GI Bleeding Liver Failure
Kidney FailureMyocardial Infarct
MWAS + SubNetSystems PharmacologyAlone (SubNet)
SubNet (0.81)MWAS+SubNet (0.85)
MWAS (0.69)
Statistics Alone (MWAS)
Comparing network biology to post-market analysis
Lorberbaum, et al. Clin. Pharmacol. Ther. (2015)
![Page 26: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/26.jpg)
MWAS+SubNet outperforms either model alone
Drug MWAS SubNet Both
Desipramine 70% 85% 100%
Darbepoetin Alfa 49% 73% 100%
Estradiol 67% 52% 75%
Frovatriptan 42% 64% 75%
Imipramine 64% 58% 67%
Myocardial InfarctSensitivity Specificity
MWAS SubNet Both
60% 74% 100%
80% 86% 100%
60% 89% 100%
89% 86% 100%
71% 89% 100%
Lorberbaum, et al. Clin. Pharmacol. Ther. (2015)
![Page 27: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/27.jpg)
Observational analysis is the fuel of scientific discovery
• Data-mining has the potential to generate billions of hypotheses we could not have conceived of
• However, like all good hypotheses, these must be rigorously tested
• Systems pharmacology reveals the molecular hypothesis of drug side effects enabling experimental validation
![Page 28: Nick Tatonetti's presentation on Systems Pharmacology at AMIA 2015](https://reader031.fdocuments.net/reader031/viewer/2022021922/587708401a28ab890e8b5d45/html5/thumbnails/28.jpg)
28
tatonettilab.org [email protected]
@nicktatonetti
Current Lab MembersRobert Moskovitch, PhD Rami Vanguri, PhD Alexandra Jacunski Tal Lorberbaum**Mary Boland Joseph Romano Yun Hao Phyllis Thangaraj Alexandre Yahi
CollaboratorsBrent Stockwell, PhD George Hripcsak, MD, MS Ziad Ali, MD, DPhil Santiago Vilar, PhD Konrad Karczewski, PhD (Broad/MGH) Joel Dudley, PhD (Mount Sinai) Patrick Ryan, PhD (OHDSI) Eric Horvitz (Microsoft Research) Ryen White (Microsoft Research) Russ Altman (Stanford)
FundingNIGMS R01GM107145 Herbert Irving Fellowship NCI P30CA013696 NIMH R03MH103957 PhRMA Foundation AstraZeneca
Thank you